1 week Ago
Avid Bioservices ( NASDAQ: CDMO ) is scheduled to announce Q1 earnings results on Monday, September 9th, after market close. The consensus EPS Estimate is -$0.04 (-33.
3% Y/Y) and the consensus Revenue Estimate is $40.82M (+8.3% Y/Y).
Over the last 2 years, CDMO has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time. More on Avid Bioservices Avid Bioservices Continues Facing Valuation Risks Despite Increased Capacity Avid Bioservices, Inc. (CDMO) Q4 2024 Earnings Call Transcript Avid Bioservices reports mixed Q4 results; initiates FY24 outlook Avid Bioservices Q4 2024 Earnings Preview Seeking Alpha’s Quant Rating on Avid Bioservices.
